Company Overview
Snapshot
Founded in February 2025 by Ido Sadan, Phantom GI operates with 1–10 employees. The company has secured funding across two rounds, including a Pre-Seed round in February 2025. Phantom GI is focused on developing a patent-pending device for percutaneous surgery.
Business overview
Phantom GI is an early-stage MedTech startup specializing in the development of a patent-pending device for percutaneous surgery. The company aims to provide a life-saving treatment for a fatal condition within the $2.5 billion market. Operating in the Health Tech & Life Sciences sector, Phantom GI serves the medical devices industry with a B2B business model, targeting markets in Southeast Asia, Europe, and North America.
Company Intelligence Q&A
- When was Phantom GI founded?
- Phantom GI was founded in February 2025.
- Who is the founder of Phantom GI?
- Ido Sadan is the Co-founder & CEO of Phantom GI.
- What is Phantom GI's primary sector?
- Phantom GI's primary sector is Health Tech & Life Sciences, specifically focusing on Medical Devices.
- What is Phantom GI's product stage?
- Phantom GI's product is currently in the R&D stage, working on a patent-pending device for percutaneous surgery.
- What type of funding has Phantom GI received?
- Phantom GI has received Pre-Seed funding in February 2025 and a grant in January 2025.